Loading
Laurus Labs Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Venkata Jayasree Kumari Tadikonda, was filed 22 Mar 2022.
Insider Decl.
91
Thresholds
n/a
Buy Volume
€230,889
9 ops. · all time
Sell Volume
€11M
62 ops. · all time
Since the insiders bought
- -50.0%Entry ₹605.80 · Close at T+365 ₹303.20
- -41.4%Entry ₹535.85 · Close at T+365 ₹314.15
- -28.6%Entry ₹682.40 · Close at T+365 ₹487.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Laurus Labs Limited Hold (neutral), based on 14 analysts. Average price target: ₹1,703.07.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 10,300 of 26,289 companies
57.0
score / 100
Value39
Quality75
FCF yld0.5%
Earn yld0.8%
EV/EBITDA·
ROE18%
Gross mgn59%
Net mgn13%
Debt/EBITDA1.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹2,069.00
Analyst consensus
14 analystsHold
₹900.00Target ₹1,703.07(-18%)₹2,520.00
Income statement
Revenue₹67.2B
Gross profit₹39.6B59% margin
EBITDA₹18.2B27% margin
Net income₹8.9B15.0% margin
Valuation
PER (trailing)102.3x
PER (forward)69.0x
P/Book21.1x
Beta0.34
Balance sheet & cash
Market cap₹1.1T
Total debt₹25.2B
Free Cash Flow₹5.5B
Debt / Equity46%
Profitability & ownership
ROE17.7%
ROA8.2%
% insiders32.0%
% institutions33.2%
Last declaration on 6 December 2024
Declarations91 total
200,000 shares@ ₹576.4053.2% of flowEquity SharesSEBI:f056e113b6d76c2ca2150ffbc16b0d83f54e802b
10,000 shares@ ₹376.00100.0% of flowEquity SharesSEBI:65a5ebe59fea5b64a320934230be0c60f5938025
3,992 shares@ ₹578.699951.9% of flowEquity SharesSEBI:533ed4ab7f20b74154ba14b1ace39f1f40980e44
Canonical exit: 14 Jun 2022 (T+90)
2,906 shares@ ₹578.699937.9% of flowEquity SharesSEBI:f42d38f3df2b5437d430c3531e677c3a8b4b41c6
Canonical exit: 12 Jun 2022 (T+90)
788 shares@ ₹578.700510.2% of flowEquity SharesSEBI:3366fdec688fd4954445e2ed651c1ee188c066c3
Canonical exit: 15 Jun 2022 (T+90)
10,000 shares@ ₹539.6671100.0% of flowEquity SharesSEBI:38648633ccebbcc5b348287b244fdaf2237aa5f6
Canonical exit: 16 May 2022 (T+90)
2,275 shares@ ₹525.9451100.0% of flowEquity SharesSEBI:9918aa918bf48f376276e65749d72798b1cc2fd3
10,245 shares@ ₹505.00100.0% of flowEquity SharesSEBI:3c64216c2911c4481747e64cfffb129684c055bf
12,000 shares@ ₹657.9167100.0% of flowEquity SharesSEBI:89cce66f57a00d5b944c713995d2af8d7b6e43a9
1,000 shares@ ₹650.007.8% of flowEquity SharesSEBI:70dd415dbf1f2fff1e417e60f5b64c1724e22ace
4,000 shares@ ₹650.9031.8% of flowEquity SharesSEBI:38a73e3679e9a0368c34fa465ac3b651400cd155
5,500 shares@ ₹657.000.0005% mcap100.0% of flowEquity SharesSEBI:3b480afbc23a058629b405c641fa3064b07d5c5c
3,000 shares@ ₹669.76430.0003% mcap100.0% of flowEquity SharesSEBI:69648c1b026d439e29642d979c59be7d7a2381e4
20,000 shares@ ₹700.000.0019% mcap5.3% of flowEquity SharesSEBI:b764e1f7fab1b1c9f44ecd5b7252fd53243b16b9
18,120 shares@ ₹703.27230.0017% mcap4.9% of flowEquity SharesSEBI:47edc5b96d5919ef4a2dcb5a7d387403d19e4e4c
67,657 shares@ ₹702.89240.0063% mcap18.2% of flowEquity SharesSEBI:8679313bcf167fe661ae23babba4951a458450ed
1,445 shares@ ₹700.99930.0001% mcap50.1% of flowEquity SharesSEBI:ff4d7d5e25c0c2d0470fdb1a36453dbb2b20936d
2,910 shares@ ₹688.650236.5% of flowEquity SharesSEBI:d7094110df1c126fb2f2988a96abed8cbf40527c
Canonical exit: 28 Sept 2021 (T+90)
5,060 shares@ ₹688.650.0005% mcap63.5% of flowEquity SharesSEBI:d841479378fac38ef620176828126f861f5e726f
15,000 shares@ ₹681.000.0013% mcap100.0% of flowEquity SharesSEBI:432bed1ca28cddc59a949970b86e29f4b361b32c
5,000 shares@ ₹686.950.0005% mcap71.5% of flowEquity SharesSEBI:37ddaa21e9f02a44f4996032e109657b05d40dd7
1,500 shares@ ₹466.170.0001% mcap6.7% of flowEquity SharesSEBI:3416b6b38ae404ebeaeeebb5147776a5a23dd514
2,100 shares@ ₹687.760.0002% mcap100.0% of flowEquity SharesSEBI:557c68364cf932a05d9a2be3ee5bb327bca5dd54
30,000 shares@ ₹686.66670.0027% mcap100.0% of flowEquity SharesSEBI:39c74a231d7ce46922cac845be4dee5da6c5a18a
6,500 shares@ ₹688.75150.0006% mcap53.7% of flowEquity SharesSEBI:bca8cc04a27c9c9810a2152f45418010ba142aa3
25 of 91 declarations
About Laurus Labs Limited
The Laurus Labs Limited record is concentrated in time: of 91 filings published between May 21, 2021 and December 6, 2024, 84 date from 2021, against 5 in 2022 and 1 in each of 2023 and 2024. This Indian healthcare company, listed in Bombay and valued at INR 1,117.9 billion, has 58 filers, who together hold 32% of the capital. No filing falls in the last twelve months.
Sales number 62 and total EUR 10.8 million, with a median of EUR 31,172. Two of them, filed on June 8, 2021, dominate: EUR 2,810,984 for Chunduru Venkata Lakshmana Rao and EUR 2,762,811 for Ravi Kumar Venkata Vantaram. Prathima Chava sold EUR 771,722 on June 29, 2021. The 9 purchases weigh only EUR 230,889 in all (median EUR 20,125), or 13% purchases among open-market trades: Madhuri Medasani, EUR 63,006 on February 15, 2022, and Venkata Jayasree Kumari Tadikonda, EUR 27,588 on March 16, 2022.
Read moreShow less
Between May 31, 2021 and June 30, 2021, 4 insiders bought EUR 70,413. Filings are published a median of 2 days after the trade.
